ACCME Responds to Senate

For the first time, the Accreditation Council for CME is initiating a review of the commercial support system that will include considering a full range of options — from leaving the process intact, to setting up a centralized grants repository, to limiting — and even prohibiting — pharmaceutical industry funding of CME.

“It's hard to believe that we could be talking about not having commercial support — we wouldn't have talked about that 10 years ago,” says Murray Kopelow, MD, ACCME

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.